维普期刊资源整合服务平台（V6.5）

73篇 您的检索式：作者名="Zocco MA"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Thrombotic risk factors in patients with liver cirrhosis:correlation with MELD scoring system and portal vein thrombosis development显示文摘	Zocco MA Di Stasio E De Cristofaro R	2009	J Hepato12009，51，4：	1
2	Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 显示文摘	Nista EC Candelli M Zocco MA	2006	Gastroenterol2006，101，9：	1
3	Thrombotic riskfactors in patients with liver cirrhosis:correlation with MELDscoring system and portal vein thrombosis development 显示文摘	Zocco MA Di Stasio E De Cristofaro R	2009	JHepatol2009，51，4：	1
4	The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure显示文摘	Di Campli C Zocco MA Gaspari R	2005	Transplant Proc2005，37，：	1
5	Levofloxaein based regimen-for the eradication of Helicobacter pylori显示文摘	Di Caro S Zocco MA Cremonini F	2002	Eur J Gastmenterol Hepatol2002，14，：	1
6	Levofloxacin based regiments for the eradication of Helicobacter pylori 显示文摘	Di Caro S Zocco MA Cremonini Ir	2002	European Journal of Gastroenterology&Hepatology2002，14，12：	1
7	Levofloxacin based triple therapy in first-line treatment for Helicobacter pylori eradication 显示文摘	Nista EC Candelli M Zocco MA	2006	Am J Gastroenterol2006，101，9：	1
8	Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis 显示文摘	Zocco MA dal Verme LZ Cremonini F	2006	Aliment PharmacolTher2006，23，11：	1
9	Thrombotic risk factors in patients with liver cirrhosis : correlation with MELD scoring system and portal vein thrombosis development 显示文摘	Zocco MA Di Stasio E De Cristofaro R	2009	J Hepatol2009，51，4：	1
10	Levofloxacin based regimens for the eradication of helicobactcr pylori 显示文摘	Dicaro S Zocco MA Cremonini F	2002	Eur J Gastroenterol Hcpatol2002，14，12：	1
11	Thromboticrisk factors in patients with liver cirrhosis:correlationwith MELD scoring system and portal vein thrombosisdevelopment显示文摘	Zocco MA Di Stasio E De Cristofaro R	2009	J Hepatol2009，51，4：	1
12	Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis显示文摘	Zocco MA dal Verme LZ Cremonini F	2006	Aliment Pharmacol Ther2006，23，11：	1
13	Mono,dual and triple moxifloxacin-basrd therapies for helicobacter pylori eradication显示文摘	Di CARO S OJETTI V Zocco MA	2002	Aliment Pharmacol Ther2002，16，3：	1
14	Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 显示文摘	Nista E Candelli M Zocco MA	2006	Am J Gastroenterol2006，101，9：	1
15	Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 显示文摘	NISTA EC CANDELLI M ZOCCO MA	2006	Am J Gastroenterol2006，101，9：	1
16	What we should know about portal vein thrombosis in cirrhotic patients:a changing perspective 显示文摘	Ponzimai FR Zocco MA Gareovich M	2013	World J Gastroenterol2013，18，36：	1
17	Beta-lactamase inhititor engances Helicobacter pylorieradication rate显示文摘	Ojetti VA Migneco A Zocco MA	2004	J Intern Med2004，255，1：	1
18	Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication显示文摘	Nista EC Candelli M Zocco MA	2006	Am J Gastroenterol2006，101，9：	1
19	Moxifloxacin-based strate-gies for first-line treatment of Helicobacter pylori infection 显示文摘	Nista EC Candelli M Zocco MA	2005	Ali-ment Pharmacol Ther2005，21，10：	1
20	Beta- lactamase inhibitor enhances Helicobacter pylori eradication rate 显示文摘	Ojetti V Migneco A Zocco MA	2004	J Intern Med2004，255，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示